nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A phase II trial of pemetrexed plus gemcitabine in locally advanced and/or metastatic transitional cell carcinoma of the urothelium
|
von der Maase, H. |
|
|
17 |
10 |
p. 1533-1538 |
artikel |
2 |
Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer
|
Sanna, G. |
|
|
17 |
10 |
p. 1512-1516 |
artikel |
3 |
Clinical relevance of melanoma micrometastases (<0.1mm) in sentinel nodes: are these nodes to be considered negative?
|
van Akkooi, A.C.J. |
|
|
17 |
10 |
p. 1578-1585 |
artikel |
4 |
Does low-molecular-weight heparin influence cancer-related mortality?
|
Ferretti, G. |
|
|
17 |
10 |
p. 1604-1606 |
artikel |
5 |
Dose-intensified bi-weekly temozolomide in patients with asymptomatic brain metastases from malignant melanoma: a phase II DeCOG/ADO study
|
Schadendorf, D. |
|
|
17 |
10 |
p. 1592-1597 |
artikel |
6 |
Evaluation of the prognostic and predictive value of p53 and Bcl-2 in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy
|
Malamou-Mitsi, V. |
|
|
17 |
10 |
p. 1504-1511 |
artikel |
7 |
Factorial design for randomized clinical trials
|
Bria, E. |
|
|
17 |
10 |
p. 1607-1608 |
artikel |
8 |
FOLFOX2 regimen in the treatment of advanced colorectal cancer: a comparison between elderly and young patients
|
Berretta, M. |
|
|
17 |
10 |
p. 1606-1607 |
artikel |
9 |
High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults
|
Pedrazzoli, P. |
|
|
17 |
10 |
p. 1479-1488 |
artikel |
10 |
in this issue
|
|
|
|
17 |
10 |
p. 1473 |
artikel |
11 |
Long-term cardiac follow-up in survivors of a malignant bone tumour
|
Brouwer, C.A.J. |
|
|
17 |
10 |
p. 1586-1591 |
artikel |
12 |
Mediastinal mature teratoma with an immature component—what about the treatment?
|
Romagnani, E. |
|
|
17 |
10 |
p. 1602-1604 |
artikel |
13 |
Merkel cell cancer of the skin
|
Pectasides, D. |
|
|
17 |
10 |
p. 1489-1495 |
artikel |
14 |
Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome
|
Wang, L. |
|
|
17 |
10 |
p. 1517-1522 |
artikel |
15 |
Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non–nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group
|
Fountzilas, G. |
|
|
17 |
10 |
p. 1560-1567 |
artikel |
16 |
Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study
|
Koopman, M. |
|
|
17 |
10 |
p. 1523-1528 |
artikel |
17 |
Real-time PCR analysis of PML-RARα in newly diagnosed acute promyelocytic leukaemia patients treated with arsenic trioxide as a front-line therapy
|
Ghaffari, S.H. |
|
|
17 |
10 |
p. 1553-1559 |
artikel |
18 |
Reply to Letter to the Editor: ‘Toxic epidermal necrolysis in patients with malignancies’, by G. Gravante, G. Esposito, M. Marianetti, D. Delogu, G. Sconocchia & A. Montone (doi:10.1093/annonc/mdl089)
|
Curigliano, G. |
|
|
17 |
10 |
p. 1601-1602 |
artikel |
19 |
Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease
|
Colleoni, M. |
|
|
17 |
10 |
p. 1497-1503 |
artikel |
20 |
Sequential high dose chemotherapy as initial treatment for aggressive sub-types of Non-Hodgkin Lymphoma: results of the international randomized phase III trial (MISTRAL)
|
Betticher, D.C. |
|
|
17 |
10 |
p. 1546-1552 |
artikel |
21 |
Table of Contents
|
|
|
|
17 |
10 |
p. ii-iii |
artikel |
22 |
The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR
|
Pfisterer, J. |
|
|
17 |
10 |
p. 1568-1577 |
artikel |
23 |
The challenge of nephroblastoma in a developing country
|
Ekenze, S.O. |
|
|
17 |
10 |
p. 1598-1600 |
artikel |
24 |
The enigma of young age
|
Aebi, S. |
|
|
17 |
10 |
p. 1475-1477 |
artikel |
25 |
The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma
|
Giné, E. |
|
|
17 |
10 |
p. 1539-1545 |
artikel |
26 |
Toxic epidermal necrolysis in patients with malignancies
|
Gravante, G. |
|
|
17 |
10 |
p. 1601 |
artikel |
27 |
Weekly docetaxel and capecitabine is not effective in the treatment of advanced gastric cancer: a phase II study
|
Orditura, M. |
|
|
17 |
10 |
p. 1529-1532 |
artikel |